Sanofi's ($SNY) decision to pull its R&D operations out of Bridgewater, NJ, and relocate to Boston has left a 1.2 million-square-foot problem for state and local economic development officials to deal with. Sanofi completed the move ahead of schedule as it pushes ahead with plans to downsize its research operations in France, reports the Star-Ledger. The state biotech group would like to see up-and-coming biotechs move into the vacated, 20-building research complex. Local officials would probably be satisfied with new tenants of all stripes. Story